Komori
geechs (7060) · TargetReframed

Exercise conditions for stock acquisition rights linked to EBITDA levels

First written in FY2022-Q2. 2 of 4 entries say "Restated". Latest entry: FY2026-H1.

4entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q2 – FY20232021: 12022: 120222023: 120232024: 020242025: 12025
Same theme, other companies
Exercise Conditions for Performance-Linked Stock Acquisition Rights for Officers and EmployeesA theme 179 companies write about · 9 as a headwind · 208 as a tailwind

geechs moved to the "Worse" side of this theme in 2025, 1 year after the typical company in this theme (2024).

5 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 159 companies compared. The sentences above are computed from all 159.Comparing 200 of the theme's 222 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1ReframedAnnual report

    「In any fiscal year from the fiscal year ending March 2026 through the fiscal year ending March 2030, holders of the stock acquisition rights may exercise the rights granted to them up to the applicable percentage set out below, if EBITDA calculated from our consolidated statements of income and consolidated statements of cash flows exceeds the relevant threshold. This percentage is referred to below as the “exercisable percentage”; any fraction of less than 1 right will be rounded down. (a) If EBITDA exceeds ¥1,500 million: exercisable percentage of 60%. (b) If EBITDA exceeds ¥2,000 million: exercisable percentage of 100%.」

    The former three-tier conditions covering the fiscal years ending March 2022 through March 2025 have been restructured into new performance-linked conditions covering the fiscal years ending March 2026 through March 2030: ¥1,500 million and 60%, and ¥2,000 million and 100%.
  2. FY2023RestatedAnnual report

    「In any fiscal year from the fiscal year ending March 2022 through the fiscal year ending March 2025, holders of the stock acquisition rights may exercise the rights granted to them, up to the applicable exercise ratio, if EBITDA calculated from our consolidated statements of income and consolidated statements of cash flows exceeds (a) ¥1,500 million, for an exercise ratio of 50%, (b) ¥2,000 million, for an exercise ratio of 80%, or (c) ¥2,500 million, for an exercise ratio of 100%.」

    The exercise conditions linked to EBITDA levels for the fiscal years ending March 2022 through March 2025 have been reconfirmed.
  3. FY2022RestatedAnnual report

    「In any fiscal year from the fiscal year ending March 2022 through the fiscal year ending March 2025, holders of the stock acquisition rights may exercise the rights granted to them, up to the applicable exercise ratio, if EBITDA calculated from our consolidated statements of income and consolidated statements of cash flows exceeds (a) ¥1,500 million, for an exercise ratio of 50%, (b) ¥2,000 million, for an exercise ratio of 80%, or (c) ¥2,500 million, for an exercise ratio of 100%.」

    The exercise conditions for stock acquisition rights linked to EBITDA levels for the fiscal years ending March 2022 through March 2025 have been reiterated.
  4. FY2022-Q2First statedAnnual report

    「In any fiscal year from the fiscal year ending March 2022 through the fiscal year ending March 2025, holders of the stock acquisition rights may exercise the rights granted to them, up to the applicable exercise ratio, if EBITDA calculated from our consolidated statements of income and consolidated statements of cash flows exceeds (a) ¥1,500 million, for an exercise ratio of 50%, (b) ¥2,000 million, for an exercise ratio of 80%, or (c) ¥2,500 million, for an exercise ratio of 100%.」

    New performance-linked conditions have been established under which the exercisable percentage of the stock acquisition rights is 50%, 80% or 100% depending on EBITDA levels for the fiscal years ending March 2022 through March 2025.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
geechs's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.